Literature DB >> 6200334

Activation and proliferation signals in mouse B cells. I. A comparison of the capacity of anti-Ig antibodies or phorbol myristic acetate to activate B cells from CBA/N or normal mice into G1.

C M Hawrylowicz, K D Keeler, G G Klaus.   

Abstract

B lymphocytes from the CBA/N mouse do not synthesize DNA when cultured with anti-Ig antibodies. However, these cells like normal B cells, do manifest increased Ia antigen expression and RNA synthesis (i.e. enter G1) when stimulated by anti-Ig, even at doses which are nonmitogenic for normal B cells. Pretreatment of both normal and CBA/N B cells with anti-Ig also primes them to give an enhanced proliferative response to lipopolysaccharide (LPS). The tumor promoter phorbol myristic acetate (PMA) also enhances RNA synthesis and Ia antigen expression in B cells from both normal and CBA/N mice. However, PMA only primes CBA/N B cells to respond to LPS: pretreatment of normal B cells with PMA causes a modest suppression of LPS-induced, and a marked suppression of anti-Ig induced, DNA synthesis. These results therefore confirm and extend earlier data showing that there are distinct activating (G0 to G1) vs. proliferative (G1 to S) signals discernible in B cells. They also suggest that the activation mechanism of CBA/N B cells is subtly different from that of any known subpopulation of normal B cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200334     DOI: 10.1002/eji.1830140308

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Activation and proliferation signals in mouse B cells. VII. Calcium ionophores are non-mitogenic polyclonal B-cell activators.

Authors:  G G Klaus; M K Bijsterbosch; M Holman
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

2.  Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cells.

Authors:  G G Klaus; C M Hawrylowicz; C J Carter
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

3.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

4.  An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.

Authors:  J S Anderson; M Teutsch; Z Dong; H H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

5.  Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies.

Authors:  G G Klaus; M K Bijsterbosch; R M Parkhouse
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

6.  Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells.

Authors:  J Mizuguchi; M A Beaven; J H Li; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation.

Authors:  A O'Garra; K P Rigley; M Holman; J B McLaughlin; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Activation and proliferation signals in mouse B cells. III. Intact (IGG) anti-immunoglobulin antibodies activate B cells but inhibit induction of DNA synthesis.

Authors:  G G Klaus; C M Hawrylowicz; M Holman; K D Keeler
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

9.  Activation and proliferation signals in mouse B cells. IV. Concanavalin A stimulates B cells to leave G0, but not to proliferate.

Authors:  C M Hawrylowicz; G G Klaus
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

10.  Activation and proliferation signals in mouse B cells. IX. Protein kinase C activators synergize with non-mitogenic anti-immunoglobulin antibodies to drive B cells into G1.

Authors:  M K Bijsterbosch; J B McLaughlin; M Holman; G G Klaus
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.